Zacks Investment Research on MSN

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $381.87, demonstrating a +1.39% change from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.5%. At ...

FDA Grants Vertex Kidney Disease Drug Breakthrough Therapy Designation

The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.
TipRanks on MSN

Vertex Pharmaceuticals completes enrollment in IA cohort of AMPLITUDE trial

Vertex also announced enrollment completion of the IA cohort of AMPLITUDE, a global Phase 2/3 clinical trial designed to assess the impact of ...
Stockhead

Vertex drives Reward underground mine on four mining fronts

Vertex Minerals (ASX:VTX) is still in the early stages of developing its underground mine, and while the production ramp-up was slowed by delays in high-voltage equipment delivery and commissioning, ...